发明名称 SUBSTITUTED BIPHENYLSULFONAMIDE DERIVATIVES AS ENDOTHELIAL ANTAGONISTS
摘要 <p>Compounds of the formula <CHEM> inhibit the activity of endothelin. The symbols are defined as follows: R<1> and R<2> are each directly bonded to a ring carbon and are each independently (a) hydrogen; (b) alkyl or alkoxy; (c) hydroxyl; (d) halo; or (e) amino; R<3> and R<4> are each directly bonded to a ring carbon and are each independently (a) hydrogen; (b) alkyl alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z<1>, Z<2> and Z<3>; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R<5>; (h) -CO2H or -CO2R<5>; (i) -Z<4>-NR<6>R<7>; (j) -Z<4>-N(R<10>)-Z<5>-NR<8>R<9>; or (k) R<3> and R<4> together may also be alkylene or alkenylene, either of which may be substituted with Z<1>, Z<2> and Z<3>, completing a 4- to 8-membered saturated, unsaturated or aromatic ring together with the carbon atoms to which they are attached; and the remaining symbols are as defined in the specification.</p>
申请公布号 CZ9600292(A3) 申请公布日期 1996.09.11
申请号 CZ19960000292 申请日期 1996.01.31
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 MURUGESAN NATESAN;BARRISH JOEL C.;STEIN PHILIP D.
分类号 C07D261/14;A61K31/34;A61K31/35;A61K31/495;A61K31/53;C07D237/06;C07D241/10;C07D261/02;C07D309/36;C07D413/12;C07D413/14;(IPC1-7):C07D261/02 主分类号 C07D261/14
代理机构 代理人
主权项
地址